Category Archives: Biotechnology

Marc Beer: The Man Who Helps Women Fight Rare Pelvic Disorders

Marc Beer is the Founding Chairman and Chief Executive Officer of one of the most influential and fastest growing a biotechnology company, Renovia Inc. For the few who don’t know, Renovia creates products for better first-line diagnosis and treatment of rare pelvic conditions, particularly in women. The company is based in Boston.

Mark Beer’s Achievements as the CEO and Founder of Renovia Inc.

 

Thanks to Marc’s experience and exceptional leadership skills, Renovia has evolved from an unknown pharmaceutical start-up to a robust commercial enterprise serving millions of people from all over the world. Marc’s vast network has also enabled the company to attract high-profile investors including, OSF Ventures, Nova Strategic Investments, Western Technology Investment, Cormorant Asset Management, and Longwood Fund. These investors have invested more than $45 billion in the company.

 

But that’s not. The visionary was also part of the team that helped create, test, and launches Leva, Renovia’s first product. Leva recently got approval from the Food and Drug Administration (FDA) thanks to Marc’s efforts and dedication. The CEO is also part of the team that is focused on helping Renovia create and deliver products that will improve the diagnosis and treatment of urinary incontinence. Urinary incontinence is a pelvic condition that, according to recent research, affects more than 250 million women around the world. The visionary has also helped bring talented people on board and is helping the company come up with better products and more effective strategies.

 

Education and Career

 

Marc is an alumnus of Miami University, where he pursued a BS degree. After completing his undergraduate studies, the talented businessman went to work at Abbott Laboratories, where he served as a marketer and a customer rep. During his stint at Abbott Laboratories, Marc helped the pharmaceutical company come up with cerebral sales and marketing strategies that beat any competition that came its way. He also helped the company expand to new regions. Learn more: https://renoviainc.com/leadership/

 

A few years later, Marc left Abbott Laboratories and joined Genzyme, where he served as VP of Global Marketing. At Genzyme, he helped create, test, and launch several products, devices, and treatments to fight the rare disease around the world.

 

In 2000, he founded ViaCell, a biotechnology company that he later sold to PerkinElmer. The exceptional leader also served as a member of the Board of Directors of ERYP. He also serves as Chairman of Good Start Genetics.

 

Renovia, a Bostom-based company and its diverse contributions to the society.

Renovia MedTech company was founded by Marc Beer who was a former chief executive officer of a pharmaceuticals company. Once in his career, he also worked at Ovascience as a strategic consultant.

 

Marc Beer has played a significant role in Renovia which has helped the society at large. One of the programs is the one that he launched worth $42M, a women health program. The raising of the fund will entail $10M of venture lending and $32M on Series B. The $32M launch will begin after collaborating with various dated products for pelvic floor disorders.

 

Renovo MedTech company is advancing diverse therapeutic and diagnostic commodities. The advancement will aid in the treatment of pelvic floor disorders, for example, urinary incontinence. Reports from various findings appraise that around 250 million women globally are affected by urinary incontinence. Leva, which was one of the commodities to be produced by the company, was approved on 2018 April by FDA.

 

One of the firms to invest in Renovia was The Longwood Fund, a healthcare investment firm. The reason behind the collaboration with Renovia was to take part in Series B. Series B was directed by Ascension ventures which were from Missouri and perceptive Advisors from New-York. The development and testing of more than four diagnostic and therapeutic commodities were to be facilitated by the funding to the program.

 

The new procreation of Leva device was not to be excluded from the program too. The collaboration with The Longwood Fund has enabled the company to share their various opinions and aspirations which they intend to achieve. The coming together with the firm, as in turn answered their prayers through perfection in diagnostic services.

 

The treatment of women with pelvic floor disorders has improved millions of lives of women affected by the diseases.

 

There is a need for combining of various diverse, innovative and proprietary device technologies and formulation of factors with a digital health platform. The step will aid in providing customers with the valuable data. The data will inform customers mainly on the newly introduced methods of treatment.

 

Exploring diversely on the knowledge and understanding of pelvic floor disorders will lessen perennial health care costs. The combining of forces was implemented through the joining of hands with The Longwood Fund. The creation of a shared pool with Longwood has eased the manner in which Renovia is delivering its services to its customers.

 

Renovo Medtech company is concerned with this program, mainly because of its interests of brings into light some issues which were not initially addressed, leaving the affected women isolated. The funding has created awareness for those affected to accept this disorder and realize that it is a condition that can be treated. Learn more : https://www.slideshare.net/MarcBeer